MS
Morgan Stanley
MS has the edge over TBBK overall, supported by stronger fundamentals and lower modeled downside.
TBBK
The Bancorp, Inc.
TBBK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
TBBK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
TBBK's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like TBBK.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
TBBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7x | $48.40 | — |
| Current | 8.5x | $48.40 | — |
| Cheap | 10x | $59.07 | +22% |
| Fair | 13x | $71.22 | +47% |
| Expensive | 15x | $83.37 | +72% |
Historical ranges are pointers, not guarantees.
TBBK has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over TBBK on the outlook, with more favorable revenue expectations.
TBBK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TBBK's earnings to grow and its profitability to improve, with its revenue holding steady.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over TBBK on earnings, with stronger typical year-over-year growth.
TBBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.88 | +21% |
| Q3 2026 | $5.67 | +19% |
| Q2 2026 | $5.32 | +15% |
| Q1 2026 | $5.14 | +16% |
| Q4 2025 | $4.92 | +15% |
| Q3 2025 | $4.78 | +21% |
| Q2 2025 | $4.64 | +21% |
| Q1 2025 | $4.42 | +20% |
| Q4 2024 | $4.29 | +23% |
TBBK's earnings per share have climbed steadily: $5.67 over the past year, up 19% from the year before, and higher year over year every quarter since late 2020.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
TBBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $175.9M | +0.7% |
| Q2 2026 | $163.5M | -9.8% |
| Q1 2026 | $161.3M | -8% |
| Q4 2025 | $172.6M | +8.2% |
| Q3 2025 | $174.6M | +39% |
| Q2 2025 | $181.2M | +46% |
| Q1 2025 | $175.4M | +42% |
| Q4 2024 | $159.6M | +34% |
TBBK's revenue has held roughly level: $176M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | -1.1 points |
| Q2 2026 | 50% | +5.5 points |
| Q1 2026 | 49% | +5.9 points |
| Q4 2025 | 43% | -4.4 points |
| Q3 2025 | 42% | -13 points |
| Q2 2025 | 44% | -14 points |
| Q1 2025 | 43% | -18 points |
| Q4 2024 | 48% | -1.9 points |
TBBK has the edge over MS on profitability, with a higher operating margin.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
TBBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $24.4M | -69% |
| Q2 2026 | $34.4M | -60% |
| Q1 2026 | $84.8M | -36% |
| Q4 2025 | -$36.8M | -144% |
| Q3 2025 | $77.6M | +55% |
| Q2 2025 | $85.4M | +460% |
| Q1 2025 | $131.7M | +79% |
| Q4 2024 | $83.7M | +37% |
TBBK has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
TBBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -645K shares |
| 1 year | -12% | -5.4M shares |
| 3 years | -25% | -13.6M shares |
| 5 years | -30% | -17.5M shares |
| Available history | -28% | -16.2M shares |
TBBK has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.5M |
| Q2 2026 | $50.5M |
| Q1 2026 | $50.3M |
| Q4 2025 | $151.5M |
| Q3 2025 | $151.3M |
| Q2 2025 | $37.9M |
| Q1 2025 | $37.7M |
| Q4 2024 | $50.5M |
TBBK spent $303M buying back its own shares over the past year, up 9.2% from the year before.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
TBBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.9x | Elevated |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -3.1x | Net Cash |
| Q4 2024 | -1.9x | Net Cash |
TBBK has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
TBBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 8.3 | Oversold |
TBBK's weekly RSI is 37 (neutral) and its Stochastic is 8 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
TBBK PE vs Financial Services Sector
| Metric | TBBK | Sector median | Relative |
|---|---|---|---|
| PE | 8.5x | 13x | 34% below |
| PE % | 3 | 63 | 60 pts below |
TBBK has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over TBBK on trend strength, trading above more of its moving averages.
TBBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $48.9 | 1.1% below |
| 20 week MA | $58.2 | 17% below |
| 50 week MA | $59.2 | 18% below |
| 100 week MA | $59.5 | 19% below |
| 200 week MA | $49.3 | 1.8% below |
TBBK is in a downtrend: it's below all five of its weekly moving averages, and 1.8% below its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over TBBK on returns for 2026, with the stronger performance.
TBBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.9 | $13.5 | +4.6% |
| 2021 | $13.5 | $24.8 | +85% |
| 2022 | $24.8 | $29.0 | +17% |
| 2023 | $29.0 | $38.6 | +33% |
| 2024 | $38.6 | $53.6 | +39% |
| 2025 | $53.6 | $69.9 | +30% |
| 2026 YTD | $69.9 | $48.4 | -31% |
TBBK has finished every year since 2020 higher, and it's down 31% so far in 2026.